These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2315476)

  • 41. [Typical findings and erroneous findings in SPECT-radioimmunoscintigraphy using 99mTc-labeled CEA antibodies in colorectal tumors].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Jul; 2(4):212-9. PubMed ID: 1504120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
    Markowitz A; Saleemi K; Freeman LM
    Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.
    Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D
    Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management.
    Corman ML; Galandiuk S; Block GE; Prager ED; Weiner GJ; Kahn D; Abdel-Nabi H; Mitchell EP; Pascucci VL; Maroli AN
    Dis Colon Rectum; 1994 Feb; 37(2):129-37. PubMed ID: 8306832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [99mTc anti-carcinoembryonic antigen in colorectal cancer].
    Frederiksen PB; Rasmussen JW; Lassen E; Fenger C; Kronborg O; Ditzel H
    Ugeskr Laeger; 1994 Mar; 156(11):1641-5. PubMed ID: 8009660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy].
    Mach JP; Bischof-Delaloye A; Curchod S; Studer A; Grob JP; Volant JC; Mosimann F; Givel JC; Douglas P; Leyvraz S
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1076-86. PubMed ID: 3499666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody.
    Carrasquillo JA; Sugarbaker P; Colcher D; Reynolds JC; Esteban J; Bryant G; Perentesis P; Yokoyama K; Rotman M; Schlom J
    Radiology; 1988 Apr; 167(1):35-40. PubMed ID: 3347742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma.
    Ernst CS; Shen JW; Litwin S; Herlyn M; Koprowski H; Sears HF
    J Natl Cancer Inst; 1986 Aug; 77(2):387-95. PubMed ID: 3461200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
    Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
    Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The localization of anti-tumour monoclonal antibodies in colorectal cancer.
    Armitage NC
    Ann R Coll Surg Engl; 1986 Nov; 68(6):302-6. PubMed ID: 3492956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels.
    Vijayakumar V; Blend MJ; Johnson D; Schnobrich K; Golick J
    Clin Nucl Med; 1992 Mar; 17(3):180-4. PubMed ID: 1611787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
    Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
    Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody.
    Muxí A; Pons F; Herranz R; Novell F; Fernández R; Filella X; García A; Solá M; Trías M; Setoain J
    Nucl Med Commun; 1993 Sep; 14(9):775-87. PubMed ID: 8233243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36).
    Armitage NC; Perkins AC; Pimm MV; Wastie ML; Baldwin RW; Hardcastle JD
    Nucl Med Commun; 1985 Oct; 6(10):623-31. PubMed ID: 3867028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72.3.
    Keenan AM; Colcher D; Larson SM; Schlom J
    J Nucl Med; 1984 Nov; 25(11):1197-203. PubMed ID: 6333494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma.
    Abdel-Nabi HH; Chan HW; Doerr RJ
    J Nucl Med; 1990 Dec; 31(12):1975-9. PubMed ID: 2266396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.
    Schlom J; Colcher D; Szpak CA; Johnston WW; Sugarbaker P; Carrasquillo JA; Reynolds JC; Larson SM
    Prog Clin Biol Res; 1989; 288():63-72. PubMed ID: 2717642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.